How do geopolitical or macroeconomic factors impact this market?

  • Dapoxetine is part of a comprehensive treatment strategy in Spain.
  • Counseling and education support medication use.
  • Spanish health authorities recommend consulting professionals first.
  • Dapoxetine has helped many men regain sexual confidence.
  • The medicine is stored safely away from children.
  • Its use is typically recommended after diagnosis by a specialist.
  • Dapoxetine's efficacy has been demonstrated in multiple Spanish studies.

Trade policies, tariffs, political stability, and macroeconomic shifts influence market growth, investment confidence, and regional demand patterns.

  • Dapoxetine was introduced to the Spanish market after regulatory approval.
  • It can enhance sexual satisfaction by delaying ejaculation.
  • Dapoxetine has a rapid onset of action, typically within hours.
  • The pharmacy distribution of dapoxetine in Spain is widespread.
  • Dapoxetine prescriptions in Spain increased in recent years.
  • It is considered a safe option when used responsibly.
  • Patients are advised to avoid alcohol when taking dapoxetine.

Organizations must monitor global trends to adapt their strategies effectively.

19. How are companies mitigating market and regulatory risks?

  • Patient privacy is protected under Spanish data protection laws (LOPDGDD).
  • Medical discussions about PE are confidential between you and your doctor.
  • You have the right to access your medical records regarding this prescription.
  • Online consultations for PE are available but must be with licensed professionals.
  • Be cautious of platforms that issue prescriptions after only a questionnaire.
  • A legitimate online service will require a virtual consultation with a doctor.
  • Ensure the online pharmacy is registered with the Spanish Council of Pharmacists.
  • Read reviews and verify contact information before using an online service.
  • Trust your instincts; if an offer seems too good to be true, it probably is.

Companies adopt risk management frameworks, diversify supply chains, implement compliance protocols, and invest in technology-driven efficiency to mitigate operational, regulatory, and market risks.

20.

What Is Dapoxetine (Priligy)?

Companies must balance innovation with operational efficiency to mitigate these risks.

17. Are there risks related to technology adoption or regulations?

Yes. Rapid technology adoption can incur high upfront costs, require skilled labor, and face integration challenges. Regulatory changes can also affect market access, product compliance, and operational strategy.

18. What is the projected market size and growth rate for the forecast period?

The market is expected to grow steadily based on technology adoption, evolving consumer behavior, and regional investment trends. CAGR and market size projections vary by region, product segment, and industry focus.

Contact us:

Mr.

Product Dosage Quantity + Bonus Price
Priligy Generic Dapoxetine60mg90 + 10 Pills265.64€ 252.99€
Priligy Generic Dapoxetine60mg30 + 6 Pills106.65€ 101.57€
Priligy Generic Dapoxetine60mg120 + 10 Pills341.26€ 325.01€
Viagra Generic150mg10 Pills36.73€ 34.98€
Cialis Generic60mg270 + 10 Pills443.96€ 422.82€
Priligy Generic Dapoxetine60mg60 + 8 Pills183.06€ 174.34€
Kamagra Soft Tabs100mg272 + 12 Pills593.42€ 565.16€
Priligy Generic Dapoxetine60mg20 + 4 Pills77.31€ 73.63€
Priligy Generic Dapoxetine60mg10 Pills47.63€ 45.36€
Priligy Generic Dapoxetine60mg180 + 10 Pills494.76€ 471.20€
Cialis Super Active20mg20 + 4 Pills92.35€ 87.95€
Viagra Generic25mg120 + 6 Pills125.56€ 119.58€
Apcalis SX Oral Jelly20mg50 + 6 Sachets146.39€ 139.42€
Viagra Generic150mg20 Pills55.02€ 52.40€

Edwyne Fernandes

US: +1 (650)-781-4080

US Toll-Free: +1 (800)-782-1768

Website: Top Trending Reports

Janssen-Cilag have submitted a Marketing Authorisation Application (MAA) in Europe for dapoxetine, a treatment for premature ejaculation (PE) in men 18-64 years of age.

Dapoxetine hydrochloride

AI, analytics, and digital platforms are increasingly influencing market scalability and efficiency.

7. How is technology shaping market dynamics?

Technologies such as AI, IoT, predictive analytics, and automation are optimizing operations, improving decision-making, and enhancing customer experience. Adoption of these technologies drives efficiency, cost reduction, and competitive differentiation.

8. What are the emerging trends across different regions?

Therapeutic Categories

Emerging trends include digital transformation, smart infrastructure, sustainability initiatives, and platform-based business models. Market maturity and investment appetite vary by region, creating unique growth opportunities.

9. How is AI or automation influencing this market?

AI and automation streamline operations, enable predictive insights, and reduce operational risks. They also improve product quality, enhance supply chain efficiency, and create opportunities for data-driven market strategies.

10.

Brand Names

Which market segments are expected to grow fastest?

High-tech, digital, and specialized segments are projected to grow fastest. Growth is often concentrated in regions with strong technology adoption, industrial investment, and favorable regulatory frameworks.

11. Which regions or countries hold the largest market share?

Market leadership typically comes from regions with advanced industrial infrastructure, high technology penetration, and strong investment in R&D. The safety and efficacy of dapoxetine for the treatment of men with PE were studied in five, double-blind, placebo-controlled, Phase III clinical trials involving more than 6000 subjects from 30 countries worldwide, including countries in North America, South America, Europe and Asia, and in Israel and South Africa. The results of all randomised studies were consistent and improvements included both increases in average intravaginal ejaculatory latency time (IELT) and improved patient-reported outcomes of increased control over ejaculation and reduced personal distress related to ejaculation. The most common adverse drug reactions reported during clinical trials were headache, dizziness, nausea, diarrhoea, insomnia and fatigue.

Brand Name Manufacturer Price Range (€) Available Forms Ratings (out of 5)
Priligy Johnson & Johnson 20-35 Tablets 4.5
Dapoxetina Español Local Pharma Co. 18-30 Tablets 4.2
RapidEct PharmaSpain 22-33 Tablets 4.0

This study will be carried out on 60 patients with lifelong premature ejaculation and non-responding to dapoxetine alone.

  • Dapoxetine is a medication used to treat premature ejaculation in men.
  • Spain approved dapoxetine for prescription to improve sexual confidence.
  • The drug works by increasing serotonin levels to delay ejaculation.
  • Dapoxetine is available in Spain under various brand names.
  • It is typically taken 1 to 3 hours before sexual activity.
  • Dapoxetine is considered a short-acting selective serotonin reuptake inhibitor.
  • The medication has been studied for its safety and efficacy in Spain.

All patients will be equally divided into 2 groups (30 patients each).

Age Group Recommended Dose (mg) Maximum Daily Dose (mg) Typical Timing Notes
18-25 30 mg 60 mg 1-3 hours before intercourse Do not exceed recommended dose
26-45 30 mg 60 mg 1-3 hours prior Take with water
46+ 30 mg 60 mg As prescribed Consult doctor beforehand

Group 1 was given on-demand 30 mg dapoxetine and 10 mg tadalafil 1 h before intercourse. Group 1 was given on-demand 30 mg dapoxetine 1 h before intercourse and apply lidocaine 5% spray on the glans penis 10 minutes the wash before intercourse.

Effect Description Changes Observed Contributing Factors
Increased Online Purchases Shift towards online pharmacies Up by 30% Lockdowns, social distancing
Reduced Prescriptions Some patients delayed doctor visits Down by 10% Healthcare access restrictions
Stock Shortages Temporary shortages in some pharmacies Occurred Supply chain disruptions

Name: Mohammed A Abu El-Hamd, MD Sohag, Egypt, 82524RecruitingMohammed Abu El-Hamd Contact:Mohammed A Abu El-Hamd, MDPhone Number: 01004139060Email: Mohammedadva@yahoo.com Sohag, Egypt, 82524RecruitingMohammed Abu El-Hamd Contact:Mohammed A Abu El-Hamd, MDPhone Number: 01004139060Email: Mohammedadva@yahoo.com Sohag, Egypt, 82524RecruitingMohammed Abu El-Hamd Contact:Mohammed A Abu El-Hamd, MDPhone Number: 01004139060Email: Mohammedadva@yahoo.com Contact:Mohammed A Abu El-Hamd, MDPhone Number: 01004139060Email: Mohammedadva@yahoo.com lifelong premature ejaculation and non-responding to dapoxetine alone. Principal Investigator: Mohammed A El-Hamd, Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University This information was retrieved directly from the website clinicaltrials.gov without any changes.

Negative Effects Of Usage

It includes various product types, applications, and end-user segments that collectively shape demand and revenue generation.

2. How is the United Arab Emirates (UAE) Dapoxetine Hydrochloride Cas 119356-77-3 Market defined across regions?

The market definition varies by region depending on economic structure, technology adoption, regulatory environment, and local consumption patterns. Each region may emphasize different segments based on industrial priorities and consumer behavior.

3. What are the key product types and applications in this market?

Chemical Formula

The market typically comprises multiple product types and applications, ranging from standard offerings to advanced or high-performance solutions. Applications span commercial, industrial, and consumer use cases depending on regional needs and sector requirements.

4. Which end-user segments are driving demand?

Demand is primarily driven by individual consumers, enterprises, and industrial organizations. Segment growth varies by region and is influenced by adoption trends, technological requirements, and evolving market needs.

5.

Mechanism of action

How has the market evolved over the last 5–10 years?

The market has experienced growth due to technology adoption, changing consumer behavior, and digital transformation. Innovation, automation, and sustainability initiatives have increasingly shaped operational and strategic decisions.

6. What factors are driving growth in the United Arab Emirates (UAE) Dapoxetine Hydrochloride Cas 119356-77-3 Market?

Key drivers include technological advancement, automation, regulatory support, rising consumer demand, and investment in innovation. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov.

Althernative Medicine

However, emerging markets often provide high growth potential despite smaller current market share.

12. How do market trends differ between developed and emerging regions?

Developed regions focus on efficiency, innovation, and advanced technologies, while emerging regions prioritize scalability, adoption of affordable solutions, and infrastructure development. Both offer unique opportunities for growth and investment.

13. Are there region-specific regulatory or policy impacts?

ATC (Anatomical Therapeutic Chemical Classification)

Regulations on safety, quality, and environmental compliance can vary widely across regions. Companies must align strategies to meet local regulatory frameworks, which can influence product development, pricing, and market entry decisions.

14. How is infrastructure or digital adoption affecting market growth?

Regions with strong digital infrastructure and technology adoption see faster operational efficiency, better analytics, and improved customer experience. Emerging regions benefit from digital transformation initiatives that accelerate market maturity.

15.

Study Registration Dates

What local market dapoxetine 30mg tablet opportunities should investors consider?

Opportunities often exist in high-growth segments, technology-driven applications, niche industries, and regions with expanding consumer demand. Investment potential is also shaped by regulatory incentives, public-private initiatives, and infrastructure development.

16. What are the main challenges facing this market?

Challenges include technological disruption, regulatory compliance, supply chain risks, high production costs, and competition. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well. Janssen Research & Development, LLCCompletedSexual Dysfunction, Physiological EjaculationGermany, Spain, Portugal, Finland, Sweden, Austria Johnson & Johnson Pharmaceutical Research & Development...CompletedSexual Dysfunction Ejaculation Sohag UniversityCompletedVitamin D, Vitamin B12 and Folic Acid Among Patients With Premature EjaculationEgypt Abant Izzet Baysal UniversityCompletedEjaculatory Dysfunction Sexual Dysfunction Male Premature (Early) EjaculationTurkey (Türkiye) PfizerCompletedEjaculationItaly, Spain, Australia, Austria, Canada, Czech Republic, France, Germany, Israel, Norway, Poland, Sweden, Turkey, Netherlands Institute for the Study of Urological Diseases,...RecruitingErectile DysfunctionGreece Centro Universitario de Ciencias de la Salud, MexicoUnknownObesity and Erectile DysfuntionMexico Saint Petersburg State University, RussiaRecruitingErectile DysfunctionRussian Federation Futura Medical Developments Ltd.CompletedErectile DysfunctionUnited States, Bulgaria, Georgia, Poland Product Avanafil CAS#330784-47-9; Vildagliptin CAS#274901-16-5Documentation: DMF, WC,COA Specification: in-house Product Oseltamivir Phosphate CAS#204255-11-8For the treatment and prevention of influenza A and B in adults and children one year and older.

Scroll to top

Dr. med. Fabienne Gretener

Werdegang

Januar 2024 bis heute
Oberärztin SenoMed AG
Schwerpunktsweiterbildung gynäkologische Senology

März 2023 – Dezember 2023
Oberärztin, SenoMed AG Bern 20%

Januar 2023 – November 2023
Assistenzärztin Psychiatrie, Klinik Meissenberg Zug

Januar 2021 – November 2022
Assistenzärztin Gynecology und Geburtshilfe, Bürgerspital Solothurn

November 2019 – Oktober 2020
Assistenzärztin Gynecology und Geburtshilfe, Kantonsspital Aarau

Januar 2017 – Juli 2019
Assistenzärztin Gynecology und Geburtshilfe, Kantonsspital Olten

Paul Laszlo Bernhard

Werdegang

Jan 2024 bis heute
Facharzt SenoMed AG – Brustzentrum Bern Biel

Aug 2019 – Dez 2023
Oberarzt Frauenklinik und Brustzentrum Bürgerspital, Solothurn, Schwerpunktweiterbildung operative Gynecology und Geburtshilfe sowie Senology

Mai 2019 Facharzttitel Gynecology & Geburtshilfe

Apr 2016 – Jul 2019
Arzt in Weiterbildung, Inselspital Bern, Universitätsklinik für Frauenheilkunde

Dez 2014 – Apr 2016
Arzt in Weiterbildung, Kantonsspital Baden

Sep 2012 – Sep 2014
Arzt in Weiterbildung, Universitätsklinikum Carl Gustav Carus, Dresden

Feb 2012 – Sep 2012
Arzt in Weiterbildung, Universitätsfrauenklinik Leipzig

Nov 2011 Approbation zum Arzt

2005 – 2011
Studium der Humanmedizin an der Charité, Universitätsmedizin Berlin

Dr. med. Patrizia Sager

Werdegang

Okt 2023 bis heute
Leiterin Weiterbildungsstätte gynäkologische Senology

Feb 2018 – bis heute
Leiterin Brustzentrum Bern Biel
Practiceinhaberin SenoMed AG

Nov 2017 – bis heute
Belegärztin Salem-Spital Bern

Jan 2013 – Okt 2017
Leitung Senology Brustzentrum Frauenklinik Universitätsspital Insel, Bern

Jan 2012 – Dez 2012
Oberärztin Gynecology / Geburtshilfe, Frauenklinik Universitätsspital Insel, Bern

Nov 2010 – Dez 2011
Leitende Ärztin Gynecology und Geburtshilfe, Frauenklinik Rheinfelden (DE)

Nov 2009 – Okt 2010
Oberärztin Gynecology und Geburtshilfe, Kantonsspital Liestal

Jan 2009 – Okt 2009
Oberärztin i.V. Gynecology und Geburtshilfe, Regionalspital Interlaken

Jun 2008 – Dez 2008
Assistenzärztin Gynecology und Geburtshilfe, Regionalspital Interlaken

Aug 2007 – Mai 2008
Assistenzärztin Gynecology und Geburtshilfe, Universitätsspital Zürich

Feb 2007 – Jun 2007
Oberärztin Gynecology und Geburtshilfe, Universitätsspital Groote Schuur, Kapstadt, Südafrika

Jan 2004 – Dez 2006
Assistenzärztin Gynecology und Geburtshilfe, Regionalspital Thun

Jan 2003 – Dez 2003
Assistenzärztin Chirurgie und Orthopädie, Regionalspital Thun

Schulen, Studium & Diplome

2023
Schwerpunkt gynäkologische Senology

2014
Diplom Senology SGGG

2013
Diplom Senology: European Academy of Senology

2010
FMH Gynecology und Geburtshilfe inkl. Schwerpunkt operative Gynecology

2003
Promotion

2002
Staatsexamen in Humanmedizin

1996 – 2002
Humanmedizinstudium Universitätsspital Basel

Mitglied- und Partnerschaften

  • Schweizerische Gesellschaft für Gynecology und Geburtshilfe SGGG
  • Schweizerische Gesellschaft für Senology SGS
  • Mitglieder Arbeitsgemeinschaft Gynäkologische Onkologie AGO, Schweiz
  • European Academy of Senology EAoS
  • SAKK Project-Group breast cancer
  • Schweizerische Gesellschaft für Ultraschall in der Medizin SGUM
  • Verbindung der Schweizer Ärzte und Ärztinnen FMH
  • Society of women in senology SWIS
  • Vorstandsmitglied Ärztenetzwerk Bern